Are you prepped for PrEP?
In February 2016, Health Canada approved the daily use of the anti-HIV drug Truvada for reducing the risk of the sexual transmission of HIV. A growing demand for PrEP has raised questions from both service providers and the communities they serve:
- What is PrEP and how effective is it?
- Who is PrEP for?
- How can clients access PrEP?
- How can access to PrEP be improved for people who need it?
The webinar will include a live Q&A with the webinar presenters.
About the presenter
Dr. Darrell Tan leads the HIV Clinical Prevention Research Unit in the Division of Infectious Diseases at the University of Toronto and is involved in leading Canada’s first demonstration project of pre-exposure prophylaxis (PrEP).
Kevin currently writes for Daily Xtra, Positive Living Magazine, and TheHomoCulture.com and is on the Board of Directors of the Health Initiative for Men. He has been using PrEP since February 2015 and resides in Vancouver.
Peter has worked as Service Access Coordinator at the AIDS Committee of Toronto for the past 14 years. As a first point of contact at ACT, he has become the point person for questions about PrEP, and he supports service users to explore their options around accessing PrEP.
Andrea is the social worker at the Immunodeficiency Clinic, Toronto General Hospital, and an adjunct lecturer with the Faculty of Social Work at the University of Toronto. She offers various types of practical and psychosocial supports to a diverse patient population at the Immunodeficiency Clinic.
Adam has been a Policy Researcher with the Canadian Treatment Action Council (CTAC) since March 2014 and also sits on the executive committee of Action Hepatitis Canada.
Please note that this webinar will be presented in English. A French PrEP webinar will be presented at a date to be announced soon. Please subscribe to CATIE’s Webinar Updates to stay informed.